Epidemiology of choriocarcinoma in Finland, 1953 to 1999

Gynecologic Oncology

Volumn 92, Issue 1, 2004, Pages 252-255

  Loukovaara, Mikko ^a   Pukkala, Eero ^b   Lehtovirta, Pentti ^a   Leminen, Arto ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

Choriocarcinoma; Epidemiology; Trophoblastic disease

Indexed keywords

ADOLESCENT; ADULT; AGE; AGRICULTURAL WORKER; ARTICLE; CALCULATION; CANCER INCIDENCE; CANCER REGISTRY; CHORIOCARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DELIVERY; FEMALE; FEMALE FERTILITY; FINLAND; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NURSE; OCCUPATION; OCCUPATIONAL HAZARD; POPULATION; PREGNANCY; PRIORITY JOURNAL; REGISTER; RISK FACTOR; UTERUS CANCER;

EID: 0742272521     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.08.039     Document Type: Article

References (18)

1. Paradinas F.J. Pathology and classification of trophoblastic tumors. Coppleson M. Gynecologic oncology. Second ed. 1992;1013-1026 Churchill Livingstone, Edinburgh.
2. Newlands E.S., Bagshawe K.D., Begent R.H.J., Rustin G.J.S., Holden L. Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br. J. Obstet. Gynaecol. 93:1986;63-69.
3. Newlands E.S., Bagshawe K.D., Begent R.H.J., Rustin G.J.S., Holden L. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br. J. Obstet. Gynaecol. 98:1991;550-557.
4. Wei P.-Y., Ouyang P.-C. Trophoblastic diseases in Taiwan. Am. J. Obstet. Gynecol. 85:1963;844-849.
5. Mills W. Chorion-carcinoma in the Midlands. Clin. Radiol. 15:1964;260-262.
6. Kolstad P., Hognestad J. Trophoblastic tumours in Norway. Acta Obstet. Gynecol. Scand. 44:1965;80-88.
7. Ringertz N. Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958-1965. Acta Obstet. Gynecol. Scand. 49:1970;195-203.
8. Teoh E.S., Dawood M.Y., Ratnam S.S. Observations on choriocarcinoma in Singapore. Obstet. Gynecol. 40:1972;519-524.
9. Baltazar J.C. Epidemiological features of choriocarcinoma. Bull. World Health Organ. 54:1976;523-532.
10. Brinton L.A., Bracken M.B., Connelly R.R. Choriocarcinoma incidence in the United States. Am. J. Epidemiol. 123:1986;1094-1100.
11. Finland in figures. Statistics Finland 20. Helsinki; 1997.
12. Teppo L., Pukkala E., Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol. 33:1994;365-369.
13. Fan C., Goto S., Furuhashi Y., Tomoda Y. Radioimmunoassay of the serum free β-subunit of human chorionic gonadotropin in trophoblastic disease. J. Clin. Endocrinol. Metab. 64:1987;313-318.
14. Cancer incidence in five continents. Muir C., Waterhouse J., Mack T., Powell J., Whelan S. IARC Sci. Publ. No. 88. vol. V:1987;. Lyon.
15. Pukkala E. Cancer risk by social class and occupation: a survey of 109 000 cancer cases among Finnish of working age. Contrib Epidemiol Biostat 1995;7:12-22, 82-90.
16. Central Statistical Office of Finland Population Census 1970: occupation and social position. Official statistics of Finland VI C:104. vol. IX:1974;. Helsinki.
17. Aranda J.M., Martinez I. Incidence of choriocarcinoma in Puerto Rico. A 15-year study. Cancer. 23:1969;506-507.
18. Shanmugaratnam K., Muir C.S., Tow S.H., Cheng W.C., Christine B., Pedersen E. Rates per 100,000 births and incidence of choriocarcinoma and malignant mole in Singapore Chinese and Malays. Comparison with Connecticut, Norway and Sweden. Int. J. Cancer. 8:1971;165-175.